AUA New Guidelines on Prostate Cancer Screening

The American Urological Association (AUA) today issued new clinical guidance about prostate cancer screening. The guidelines were announced at the association’s annual meeting by Peter Carroll, chair of the panel that developed the Statement.  The AUA states that its guidelines directly contrast with recent recommendations issued by other major groups.

AUA advises that the prostate-specific antigen (PSA) test should be offered to well-informed men aged 40 years or older who have a life expectancy of at least 10 years.

New active surveillance more individualized

For Low Risk Prostate Cancer,  Personalized Monitoring An Option

Active surveillance may be a viable option for some men with prostate cancer. Regular tests and careful tracking of any changes in the patient’s disease risk over time are imperative to ensure good outcomes, according to researchers in Toronto presenting at the annual meeting of the American Urological Association (AUA).